Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex Launches Innovative, Industry-Focused Websites

Published: Friday, February 22, 2013
Last Updated: Friday, February 22, 2013
Bookmark and Share
Company builds on award-winning web presence with new digital experience.

Phenomenex Inc. announces an entirely new "Smart Web" design, organized for the key industries the company serves. Redesigned from the ground up, the industry-specific gateways function as complete digital consultants, helping users find answers by providing customized content and newsletters along with product selection and method development tools.

Already recognized as an innovator in web design, Phenomenex has created the new industry sites to address overall user movement toward researching, purchasing and applying products completely with web tools. The digital experience is designed to anticipate customer needs and questions.
 
"Smart Web" industry-specific sites are now live for pharmaceutical, food and beverage, clinical research, environmental, forensic toxicology and fuels customers.

"We have customers across the globe, working at all hours, who are searching online for answers. We wanted to give them the same high level of support and service in the digital space that they have come to expect when working with us in person," explains Michael Garriques, Internet marketing manager at Phenomenex. "They want immediate information to help them quickly figure out which column is best for their application, purchase that column and then develop the most effective methods for their compounds. Our in-house web team has broken new ground and created an easy-to-use 'digital experience' designed to give customers the answers they need from anywhere at anytime."

In 2011, Phenomenex received the award for best biotechnology website in the Web Marketing Association's Web Award competition. The Phenomenex web tools are available across platforms and across languages including Chinese and Korean. The company has been regularly developing new web tools that enhance the user experience. Phenomenex's proprietary structure search capability, enhanced last year, enables researchers to find a method by simply drawing the chemical structure - something that is second nature to them. In addition to saving time, this approach is easy for researchers at all experience levels and, because chemical structures are universal throughout the world, it is equally convenient for users in all countries.

"Structure Search is a nice addition to your already excellent application search tools. Phenomenex has become my first web stop when searching for GC and LC applications in our lab. Kudos," commented Brandon Doss  of Algenol Biofuels.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!